Search Results - M. Heiblig

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER... by E. Raffoux, S. De Botton, L. Ades, M. Carré, T. Cluzeau, C. Saillard, M. Heiblig, F. Beckerich, L. Gastaud, A. Dupuis, U. Richez, P.-Y. Dumas

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    B08 | UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN ALL PATIENTS WITH RELAPSED OR REFRACTORY KMT2AR ACUTE LEUKEMIA by C. Papayannidis, I. Aldoss, G. Issa, J. Blachly, M. Thirman, G. Mannis, M. Arellano, J. Dipersio, E. Traer, M. Zwaan, N. Shukla, B. Cuglievan, C. Grove, M. Greenwood, C. Mcmahon, A. Perl, R. Stone, D. Dickens, M. Heiblig, A. Žučenka, P. Montesinos, I. Mantzaris, T. Kovacsovics, P. Shami, L. Yu, R. Bagley, A. Smith, E. Stein

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: